Request Legal Help Now - Free

Omnicare, Inc.

This is a settlement for the Nursing Homes lawsuit.

Chicago, IL: (Jun-18-07) The Inspector General of the United States Department of Health and Human Services recognized a significant whistleblower action against the nationwide pharmacy Omnicare, Inc. The suit alleged that Omnicare, the nation's largest pharmacy for nursing homes, switched drugs to garner huge profits by evading federal and state price limits. The federal false claims charge was filed by Illinois pharmacist Bernard Lisitza and his Chicago attorney, and was fought over five years.

The charges included allegations that Omnicare illegally switched the drugs of senior citizens in nursing homes and other facilities. The charges primarily involved the generic forms of the popular drugs Zantac and Prozac. Ranitidine, the generic form of Zantac, typically came in tablets. Given its popularity, the government set maximum prices that Medicaid would pay for the tablets. Ranitidine capsules were infrequently prescribed, and had no maximum prices. Allegedly, Omnicare switched patients' prescriptions for ranitidine tablets to the expensive capsules, costing taxpayers up to four times as much. For Prozac, Omnicare allegedly switched prescribed capsules to tablets. In a settlement reached, Omnicare agreed to pay $49.5 million to resolve allegations. [PR WEB: OMNICARE WHISTLEBLOWER]

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please click the link below.
Published on Jun-22-07


Fields marked * are mandatory. Please read our comment guidelines before posting.


Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.
*Your Comment:

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.
Request Legal Help Now! - Free